Recombinant IL6 (Siltuximab Biosimilar) antibody
Quick Overview for Recombinant IL6 (Siltuximab Biosimilar) antibody (ABIN7487790)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Siltuximab Biosimilar - Anti-IL6 mAb
-
Characteristics
- Antibody Type: IgG1Kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 4°C for short term, -20°C for long term
-
-
- IL6 (Siltuximab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
Siltuximab
The Siltuximab antibody is a chimeric mouse/human therapeutic antibody obtained from mouse hybridoma. It is one of several IgG1 antibodies known to bind the human interleukin 6 (IL-6) molecule, a soluble glycoprotein with a key role in pro-inflammatory responses. IL-6 is one of the main proinflammatory cytokines overexpressed in multiple pathologies (e.g. viral infections, rheumatoid arthritis, MCD, etc.).
Target
-